Arnaud Bourreille - Concepedia

Author

Arnaud Bourreille

Also Known As

A Bourreille, A. BOURREILLE, A. Bourreille, Arnaud Bourreille, Bourreille, A., Bourreille, Arnaud, Edouard Louis, Fabrizio Bossa

257

Publications

9.2K

Citations

H-Index

Concepts

All Affiliations

Inserm Centre Hospitalier Universitaire de Nantes Nantes Université Assistance Publique – Hôpitaux de Paris Hôpital Saint-Antoine

About

Arnaud Bourreille is an author at Inserm specializing in medicine, gastroenterology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	33	3.8K
2	Allergy	5	5	702
3	Health Sciences	2	2	41
4	Public Health	2	2	390
5	Engineering	1	1	13

Arnaud Bourreille

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial David Laharie, Arnaud Bourreille, Julien Branche, The Lancet InflammationAnti-inflammatoryGastroenterologyIntravenous SteroidsUlcerative Colitis	2012	633
Enteric Glia Regulate Intestinal Barrier Function and Inflammation Via Release of S-Nitrosoglutathione Tor Savidge, Paul Newman, Charalabos Pothoulakis, Gastroenterology InflammationInflammation Via ReleaseAutoimmune DiseaseMucosal ImmunologyMedicine	2007	425
Ineffectiveness of <i>Lactobacillus johnsonii</i> LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial Philippe Marteau, Marc Lémann, Philippe Seksik, Gut	2005	409
Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial Marc Lémann, Jean–Yves Mary, Bernard Duclos, Gastroenterology InflammationAnti-inflammatoryInfliximab Plus AzathioprineRandomized Placebo-controlled TrialImmunology	2006	370
Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease Laurent Beaugerie, Magali Svrcek, Philippe Seksik, Gastroenterology EpidemiologyCancer EpidemiologyMedicineProspective Observational CohortClinical Epidemiology	2013	353
Resilience of the Dominant Human Fecal Microbiota upon Short-Course Antibiotic Challenge Marie France De La Cochetiere, Tony Durand, Patricia Lepage, Journal of Clinical Microbiology	2005	316
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study Yoram Bouhnik, Franck Carbonnel, David Laharie, Gut	2017	315
Structural alterations of the intestinal epithelial barrier in Parkinson’s disease Thomas Clairembault, Laurène Leclair‐Visonneau, Emmanuel Coron, Acta Neuropathologica Communications	2015	287
Distinct expression of interleukin (IL)-36<b>α, β</b> and <b>γ</b>, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease Marie‐Astrid Boutet, Géraldine Bart, Mélanie Gahier Penhoat, Clinical & Experimental Immunology ImmunologyImmune RegulationAntagonists Il-36raInnate ImmunityIl-36 Cytokines	2015	265
Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn’s disease: a prospective study Arnaud Bourreille Gut	2006	222

Page 1